Advisors Asset Management’s BlackRock Science and Technology Term Trust BSTZ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-41,754
Closed -$818K 1471
2022
Q2
$818K Sell
41,754
-1,200
-3% -$28.1K 0.02% 811
2022
Q1
$1.26M Sell
42,954
-653
-1% -$19.5K 0.02% 741
2021
Q4
$1.7M Buy
43,607
+12
+0% +$479 0.02% 665
2021
Q3
$1.68M Sell
43,595
-440
-1% -$17.9K 0.03% 642
2021
Q2
$1.84M Sell
44,035
-450
-1% -$17.1K 0.03% 622
2021
Q1
$1.59M Buy
44,485
+11,574
+35% +$422K 0.02% 671
2020
Q4
$1.2M Buy
32,911
+19,408
+144% +$598K 0.02% 720
2020
Q3
$346K Buy
+13,503
New +$337K 0.01% 1027

Other funds holding BSTZ

Advisors Asset Management's BSTZ Position: Q3 2022 in Review

Advisors Asset Management sold out of BlackRock Science and Technology Term Trust (BSTZ) in Q3 2022, closing a stake of 41,754 shares — an estimated $818K sold.

Advisors Asset Management first reported a position in BSTZ in Q3 2020 and held it in 8 quarters. The position peaked at $1.84M in Q2 2021. 81 funds tracked by Wall St. Rank hold BSTZ as of Q3 2022.

  • Advisors Asset Management reported no remaining BlackRock Science and Technology Term Trust position as of Q3 2022 after selling out during the quarter.
  • Advisors Asset Management sold 41,754 BlackRock Science and Technology Term Trust shares in Q3 2022, an estimated $818K.
  • Advisors Asset Management first reported a position in BlackRock Science and Technology Term Trust in Q3 2020 and held it in 8 quarters.
  • Advisors Asset Management's BlackRock Science and Technology Term Trust position peaked at $1.84M in Q2 2021.
  • 81 funds tracked by Wall St. Rank held BlackRock Science and Technology Term Trust as of Q3 2022.

Based on Advisors Asset Management's 13F filing for Q3 2022, filed 8 Nov 2022.